Email Updates

Search form

You are here

Webinar & Meeting Reports

  • March 12, 2015

    This webinar featured Jean-Michel Molina of the French research agency ANRS and Sheena McCormack of the UK Medical Research Council discussing the data from the IPERGAY and PROUD studies, respectively. Both trials evaluated oral TDF/FTC (brand name Truvada) as PrEP in gay men and other men who have sex with men, and both reported high levels of protection against HIV acquisition.

  • March 11, 2015

    This webinar featured Wafaa El-Sadr, principal investigator of HPTN 065, which evaluated the use of cash incentives in improving outcomes for people living with HIV in the United States.

  • March 9, 2015

    This webinar featured Helen Rees, principal investigator of the FACTS 001 microbicide trial of vaginal 1% tenofovir gel, and Jared Baeten, co-chair of Partners PrEP.

  • February 23, 2015 to February 26, 2015

    At the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, new data on oral PrEP and vaginal tenofovir microbicide gel emerged that have implications for HIV prevention worldwide. Read on for a summary of the news.

  • February 11, 2015

    IRMA, AVAC and the Microbicide Trials Network (MTN) provided an update on the Phase II safety and acceptability study MTN 017 (now closed to accrual) and looked at potential future directions for rectal microbicide research.

  • February 6, 2015

    Hosted by the National Black Leadership Commission on AIDS, Inc., in recognition of National African American HIV/AIDS Awareness Day, as a community forum engaged discussion on the Intersection of Health, Education & Community in the fight to End AIDS.

  • February 5, 2015

    Report co-author, Dr Mary Moran, and international key commentators discussed the report's findings and health funding decisions for the future. The first G-FINDER Reproductive Health survey reported on 2013 global investment into research and development (R&D) for new reproductive health products for developing countries. It covered investment for post-partum haemorrhage, contraceptives, non-HIV STIs, multipurpose prevention technologies and platform technologies.

  • February 2, 2015
    A panel of experts taught the latest information, facts and controversies surrounding PrEP and Truvada.
  • January 28, 2015

    The Nigerian LGBT Community in New York City hosted a private screening of the documentary, Veil of Silence. A panel discussion with prestigious representatives from the international LGBT movements, government and health sectors was present.

  • January 15, 2015

    The 12th annual African American Leadership Conference on HIV/AIDS and other health disparities was a catalyst for change, bringing together and bridging perspectives from various disciplines of public health to address health equity and social justice in order to meet the challenge of improving black gay men's health. 

Pages